Show Summary Details
Page of

Pulmonary hypertension 

Pulmonary hypertension
Pulmonary hypertension

Juan Carlos Kaski

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 December 2020

Introduction 308

Investigations/diagnosis 308

Classification/prognosis 309

Treatment 310

Clinical trials 314

Pulmonary hypertension (PH) is characterized by an increase in BP in the lung vasculature that leads to shortness of breath, dizziness, syncope, chest pain, and other symptoms, all of which are exacerbated by exertion. PH can be a severe condition with a markedly reduced exercise tolerance and lead to heart failure and death....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.